Showing 1231-1240 of 5810 results for "".
EXELO2 by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exelo2-by-quantel-derma/19448/EXELO2 by Quantel Derma is a versatile laser system for fractional treatments and full ablation for the treatment of wrinkles and scars. Shape and size of the treatment area can be set directly at the scanner hand-piece. EXCELO2 offers Random Scanning for better aesthetic results and Full Ablation MKelly on CoolSculpting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/kelly-on-coolsculpting/19462/Watch to hear Kelly discuss results of the CoolSculpting procedure he had done to his abdomen.DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
https://practicaldermatology.com/topics/skin-of-color/dermwire-tv-extra-dr-ruiz-gep-testing-scc/29497/Emily Ruiz, MD, MPH, FAAD, a Mohs surgeon at Brigham and Women's Hospital and cutaneous oncologist at Dana-Farber Cancer Institute, discusses her recent Future Oncology article, "Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile."Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.Fighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Telephone Mystery Shopping and Converting New Patients
https://practicaldermatology.com/issues/april-2025/telephone-mystery-shopping-and-converting-new-patients/35621/Even with today’s market focused on online digital marketing, a practice’s biggest revenue source opportunity still seems to be the phones. The first interaction most new patients have with a practice is on the phone, which used to be about 99% of the time; now, we believe it is about 80%.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.Updates in Vulvar Dermatology
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-vulvar-dermatology/33012/Melissa Mauskar, MD, an associate professor and director of the vulvar heatlh program at UT Southwestern Medical Center, talks about the importance of having dermatologists promote vulvar health and regular examination, while also working to reduce patient anxiety.Acne and Rosacea: Dr. Harper
https://practicaldermatology.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.Bring Pediatric Pearls Into Practice
https://practicaldermatology.com/conferences/maui-derm-2024/bring-pediatric-pearls-into-practice/20265/Resident Of Distinction Award-winner Maria Buethe, MD, PhD, a pediatric dermatology fellow at Rady Children’s Hospital in San Diego, talks about her favorite session at Maui Derm 2024 sharing technical and practice pearls for the treatment of dermatological conditions in children, including an inter